scholarly article | Q13442814 |
P356 | DOI | 10.1359/JBMR.041101 |
P698 | PubMed publication ID | 15647822 |
P2093 | author name string | Michael Amling | |
Johannes M Rueger | |||
Matthias Priemel | |||
Matthias Gebauer | |||
Thorsten Schinke | |||
Andreas Niemeier | |||
Arndt F Schilling | |||
Thomas Streichert | |||
Christian Münch | |||
P2860 | cites work | Parathyroid hormone is essential for normal fetal bone formation | Q24551862 |
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene | Q28511232 | ||
Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group | Q46981325 | ||
Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation | Q55983064 | ||
P433 | issue | 2 | |
P304 | page(s) | 274-282 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
P1476 | title | Increased bone formation in mice lacking apolipoprotein E. | |
P478 | volume | 20 |
Q34033108 | An ELISA-based method to quantify osteocalcin carboxylation in mice |
Q46014277 | ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. |
Q42808286 | Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice |
Q33969674 | Apolipoprotein E gene E2/E2 genotype is a genetic risk factor for vertebral fractures in humans: a large-scale study |
Q50770025 | Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB. |
Q35130348 | Associations of APOE gene polymorphisms with bone mineral density and fracture risk: a meta-analysis. |
Q39137277 | Bone Cell Bioenergetics and Skeletal Energy Homeostasis |
Q36590967 | Bone and high-density lipoprotein: The beginning of a beautiful friendship |
Q28087117 | Bone and the regulation of global energy balance |
Q33897511 | Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molars |
Q37624806 | Effects of bioactive lipids and lipoproteins on bone. |
Q42001274 | Fatty acid metabolism by the osteoblast. |
Q35608491 | HDL cholesterol and bone mineral density: is there a genetic link? |
Q26777956 | High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms |
Q38743436 | High-density lipoprotein (HDL) metabolism and bone mass |
Q36539906 | Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo |
Q39645392 | Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells |
Q30416092 | Intervertebral disc degeneration and ectopic bone formation in apolipoprotein E knockout mice |
Q47973219 | Intracellular lipid droplets support osteoblast function |
Q39374128 | Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease |
Q90167859 | Lowering circulating apolipoprotein E levels improves aged bone fracture healing |
Q28593424 | Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis |
Q35745608 | Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. |
Q33838946 | Quantification of Bone Fatty Acid Metabolism and Its Regulation by Adipocyte Lipoprotein Lipase |
Q36751963 | Sirt1 is involved in decreased bone formation in aged apolipoprotein E-deficient mice |
Q34386283 | The atherogenic Scarb1 null mouse model shows a high bone mass phenotype |
Q36118754 | The effect of experimental osteoporosis on bone regeneration: part 2, proteomics results. |
Q92966156 | The role of osteoblasts in energy homeostasis |
Q91393746 | Western-type diet differentially modulates osteoblast, osteoclast, and lipoblast differentiation and activation in a background of APOE deficiency |